About Qualigen Therapeutics, Inc. - Common Stock (QLGN)
Qualigen Therapeutics Inc is a biotechnology company focused on developing and commercializing innovative therapies and diagnostics for various medical conditions. Its primary mission is to enhance healthcare solutions through its proprietary technologies, particularly in the fields of oncology and infectious diseases. The company offers a range of products, including its advanced diagnostic platforms that aim to facilitate quicker and more accurate disease detection, as well as therapeutic candidates designed to improve treatment outcomes for patients facing serious health challenges. Through its cutting-edge research and development efforts, Qualigen seeks to contribute to the future of personalized medicine and improve the quality of life for patients worldwide. Read More
Myseum Inc. (NASDAQ: MYSE), a privacy-first social media and technology innovator, is capturing investor and media attention this week as CEO Darin Myman takes to the airwaves, sharing his vision for how Myseum’s technology could dramatically disrupt the social media landscape as we know it. The market has taken notice. MYSE shares have been active this week , closing Wednesday, October 22, 2025, at $2.68 and surging to an intraday high of $3.07 on Thursday on strong volume — reflecting growing investor enthusiasm as the company’s technology gains wider recognition.
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Qualigen Therapeutics Inc. shares exploded in Thursday's after-hours trading after the company partnered with digital asset firm BitGo to support its multi-asset cryptocurrency treasury strategy.
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outstanding shares is at $87.2 million.
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy”), a fast-growing consumer health and wellness company, today announced two major leadership appointments to accelerate growth in the $100 billion+ global functional beverage and energy drink market .
